Medtronic is submitting this report to comply with fda reporting regulations under 21 cfr parts 4 and 803.This report is based upon information obtained by medtronic, which the company may not have been able to fully investigate or verify prior to the date the report was required by the fda.Medtronic has made reasonable efforts to obtain more complete information and has provided as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.In particular, this report does not constitute an admission by anyone that the product described in this report has any ¿defects¿ or has ¿malfunctioned¿.These words are included in the fda 3500a form and are fixed items for selection created by the fda to categorize the type of event solely for the purpose of regulatory reporting.Medtronic objects to the use of these words and others like them because of the lack of definition and the connotations implied by these terms.This statement should be included with any information or report disclosed to the public under the freedom of information act.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.A good faith effort will be made to obtain the applicable information relevant to the report.If information is provided in the future, a supplemental report will be issued.
|
A venaseal closure system was used for treatment of the great saphenous vein (gsv) in the left leg.It was reported the patient had an allergic reaction to the glue (sic) - rash over whole body, the patients vision was affected and experienced hair loss, the date of onset of symptoms was the next day.No challenges or deviations related to the location of the catheter tip prior to initial delivery of adhesive.The catheter tip was positioned 5cm caudal to sfj.No compression of the gsv.Procedure was completed as normal, the alleged reaction occurred post op.The patient has seen a physician for treatment and the gp prescribed steroids.Self limiting rash on treated leg completely resolved approx one month later.
|